# REVANCE THERAPEUTICS INC (RVNC)

> Institutional ownership reported to the SEC as of Q1 2025, from Form 13F filings. Source: https://holderbook.com/stocks/RVNC/

- Reporting holders: 2
- Reported value: $425.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [DekaBank Deutsche Girozentrale](https://holderbook.com/funds/1456228-dekabank-deutsche-girozentrale/) | $425.0K | 86,100 | 0.0% | 19 |
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $44 | 0 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2025 | 2 | $425.0K |
| Q4 2024 | 181 | $282.0M |
| Q3 2024 | 210 | $442.8M |
| Q2 2024 | 177 | $219.2M |
| Q1 2024 | 191 | $447.2M |
| Q4 2023 | 197 | $709.5M |
| Q3 2023 | 190 | $921.5M |
| Q2 2023 | 215 | $2.2B |
| Q1 2023 | 219 | $2.6B |
| Q4 2022 | 193 | $1.6B |
| Q3 2022 | 187 | $2.2B |
| Q2 2022 | 165 | $801.3M |